ClinicalTrials.govpublic full text
Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations
non-small cell lung carcinoma, urothelial carcinoma, gastrointestinal carcinoma, non-colon, upper aerodigestive tract carcinoma, regorafenib, afatinib, targeted therapy, cabozantinib, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 841474
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.